Heart Rhythm Case Reports Publishes First Use of AI-Guided ECG Mapping for Left Bundle Branch Area Pacing Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, has announced the…
Positive Phase 2 Alzheimer’s Study Data Published, Met Primary and Secondary Endpoints Sinaptica Therapeutics, Inc., a clinical-stage company pioneering personalized neuromodulation therapies for Alzheimer’s and other neurodegenerative diseases, has announced…
Click Therapeutics Unveils New Brand Identity to Strengthen Leadership in Software as Prescription Treatments Click Therapeutics, Inc. (“Click”), a pioneer in the development of prescription medical treatments, has unveiled a…
NanoVibronix Announces Distribution Agreement with Dukehill Healthcare in Australia NanoVibronix, Inc. (NASDAQ: NAOV), a leading medical technology company specializing in non-invasive therapeutic devices, has announced the renewal and expansion of…
Predictmedix AI Closes $100,000 Third Tranche and Launches Smart Health AI Stations Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP), a leader in AI-powered health screening solutions, is excited…
RenovoRx Reports Initial Revenues from RenovoCath® and Phase III TIGeR-PaC Trial Update RenovoRx, Inc. (Nasdaq: RNXT), a life sciences company focused on developing innovative targeted oncology therapies and commercializing RenovoCath®,…
Epitel’s REMI EEG System Gets Expanded FDA Clearance for Patients Aged One and Up Epitel, a leader in AI-driven brain health solutions, has announced that the U.S. Food and Drug…
ENDRA Life Sciences Announces Strategy for Early Detection and Management of Metabolic Diseases with GLP-1 Therapies ENDRA Life Sciences Inc. (NASDAQ: NDRA), a leader in Thermo-Acoustic Enhanced UltraSound (TAEUS®) technology,…
Cell Therapy for Male Urethral Stricture: BEES-HAUS Trial at Edogawa Hospital, Japan Urethral stricture, a condition that affects men across all age groups but becomes more prevalent after the age…
SBC Medical Group Reports Q4 and Full Year 2024 Financial Results SBC Medical Group Holdings Incorporated (NASDAQ: SBC), a global leader in aesthetic practice management services and products, has announced…
ACC 2025: Sensydia CPS™ Accurately Assesses Mean Pulmonary Artery Pressure Non-Invasively Sensydia, a clinical-stage company focused on non-invasive cardiac assessments, recently showcased promising clinical findings from a study on its…
Global Cancer Antibody Drug Conjugates Market Poised for $40 Billion Growth by 2030 The global market for cancer antibody-drug conjugates (ADCs) is experiencing rapid growth, with projections indicating an increase…